JAMES P. SCANNELL

526 total citations
19 papers, 401 citations indexed

About

JAMES P. SCANNELL is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, JAMES P. SCANNELL has authored 19 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in JAMES P. SCANNELL's work include Microbial Natural Products and Biosynthesis (11 papers), Chemical Synthesis and Analysis (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). JAMES P. SCANNELL is often cited by papers focused on Microbial Natural Products and Biosynthesis (11 papers), Chemical Synthesis and Analysis (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). JAMES P. SCANNELL collaborates with scholars based in Switzerland and United States. JAMES P. SCANNELL's co-authors include David L. Pruess, Arthur Stempel, Frank Worthington Allen, Arthur M. Crestfield, HELEN A. AX, George H. Hitchings, Thomas H. Williams, Thomas Williams, Thomas H. Williams and Julius Berger and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, The Journal of Organic Chemistry and Experimental Biology and Medicine.

In The Last Decade

JAMES P. SCANNELL

19 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JAMES P. SCANNELL Switzerland 12 259 133 113 54 34 19 401
Ulfert Hornemann United States 15 271 1.0× 179 1.3× 160 1.4× 33 0.6× 27 0.8× 42 468
C. Pidacks United States 9 155 0.6× 175 1.3× 55 0.5× 53 1.0× 16 0.5× 12 398
Nike R. Plessas United States 10 294 1.1× 387 2.9× 81 0.7× 45 0.8× 21 0.6× 17 533
TOMIZO NIWA United Kingdom 11 212 0.8× 197 1.5× 127 1.1× 50 0.9× 18 0.5× 14 387
Joel G. Whitney United States 9 198 0.8× 194 1.5× 173 1.5× 22 0.4× 26 0.8× 15 425
HELEN A. AX United States 9 177 0.7× 135 1.0× 164 1.5× 35 0.6× 19 0.6× 18 348
C. A. Claridge United States 10 187 0.7× 85 0.6× 114 1.0× 42 0.8× 10 0.3× 20 324
Venancio Deulofeu Argentina 13 250 1.0× 249 1.9× 102 0.9× 61 1.1× 55 1.6× 53 502
Katsuya Tawara Japan 12 96 0.4× 142 1.1× 76 0.7× 47 0.9× 15 0.4× 22 352
Ch. Tamm Switzerland 10 192 0.7× 99 0.7× 146 1.3× 70 1.3× 15 0.4× 19 396

Countries citing papers authored by JAMES P. SCANNELL

Since Specialization
Citations

This map shows the geographic impact of JAMES P. SCANNELL's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JAMES P. SCANNELL with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JAMES P. SCANNELL more than expected).

Fields of papers citing papers by JAMES P. SCANNELL

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JAMES P. SCANNELL. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JAMES P. SCANNELL. The network helps show where JAMES P. SCANNELL may publish in the future.

Co-authorship network of co-authors of JAMES P. SCANNELL

This figure shows the co-authorship network connecting the top 25 collaborators of JAMES P. SCANNELL. A scholar is included among the top collaborators of JAMES P. SCANNELL based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JAMES P. SCANNELL. JAMES P. SCANNELL is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Evans, Ralph H., et al.. (1983). Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. II. Fermentation, isolation and structure.:II. FERMENTATION, ISOLATION AND STRUCTURE. The Journal of Antibiotics. 36(3). 213–216. 2 indexed citations
2.
Evans, Ralph H., et al.. (1983). Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. II. Fermentation, isolation and structure.. The Journal of Antibiotics. 36(3). 213–216. 22 indexed citations
3.
LeMahieu, Ronald A., HELEN A. AX, John F. Blount, et al.. (1976). A new semisynthetic macrolide antibiotic 3-O-oleandrosyl-5-O-desosaminylerythronolide a oxime.. The Journal of Antibiotics. 29(7). 728–734. 11 indexed citations
5.
SCANNELL, JAMES P., David L. Pruess, John F. Blount, et al.. (1975). Antimetabolites produced by microorganisms. XII. (S)-alanyl-3-(.ALPHA.-(S)-chloro-3-(S)-hydroxy-2-oxo-3-azetidinylmethyl)-(S)-alanine, a new .BETA.-lactam containing natural product.. The Journal of Antibiotics. 28(1). 1–6. 17 indexed citations
6.
SCANNELL, JAMES P., HELEN A. AX, & William Morris. (1974). Modern approach to the isolation and characterization of L-ascorbic acid (vitamin C ). Journal of Agricultural and Food Chemistry. 22(3). 538–539. 1 indexed citations
7.
Pruess, David L. & JAMES P. SCANNELL. (1974). Antimetabolites from Microorganisms. Advances in applied microbiology. 17(0). 19–62. 22 indexed citations
8.
Pruess, David L., et al.. (1974). Antimetabolites produced by microorganisms. XI. 1-(S)-hydroxy-2-(S, S)-valylamido-cyclobutane-1-acetic acid.. The Journal of Antibiotics. 27(10). 754–759. 7 indexed citations
9.
Pruess, David L., JAMES P. SCANNELL, HELEN A. AX, et al.. (1974). ANTIMETABOLITES PRODUCED BY MICROORGANISMS. X. The Journal of Antibiotics. 27(4). 229–233. 41 indexed citations
10.
Pruess, David L., et al.. (1973). ANTIMETABOLITES PRODUCED BY MICROORGANISMS. VII1). The Journal of Antibiotics. 26(5). 261–266. 13 indexed citations
11.
SCANNELL, JAMES P., et al.. (1972). ANTIMETABOLITES PRODUCED BY MICROORGANISMS. VI 1) L-N5-(1-IMINOETHYL) ORNITHINE. The Journal of Antibiotics. 25(3). 179–184. 18 indexed citations
12.
SCANNELL, JAMES P., et al.. (1972). ANTIMETABOLITES PRODUCED BY MICROORGANISMS. V1) L-2-AMINO-4-METHOXY-TRANS-3-BUTENOIC ACID. The Journal of Antibiotics. 25(2). 122–127. 58 indexed citations
13.
SCANNELL, JAMES P., et al.. (1971). ANTIMETABOLITES PRODUCED BY MICROORGANISMS. III 2-AMINOPURINE-6-THIOL (THIOGUANINE). The Journal of Antibiotics. 24(5). 328–329. 10 indexed citations
14.
SCANNELL, JAMES P., et al.. (1971). ANTIMETABOLITES PRODUCED BY MICROORGANISMS. II. The Journal of Antibiotics. 24(4). 239–244. 57 indexed citations
15.
SCANNELL, JAMES P., et al.. (1970). L-3-(2, 5-DIHYDROPHENYL) ALANINE, AN ANTIMETABOLITE OF L-PHENYLALANINE PRODUCED BY A STREPTOMYCETE. The Journal of Antibiotics. 23(12). 618–619. 18 indexed citations
16.
SCANNELL, JAMES P., et al.. (1969). Biosynthesis of coumermycin A1: incorporation of L-proline into the pyrrole groups.. PubMed. 9. 139–43. 9 indexed citations
17.
SCANNELL, JAMES P. & George H. Hitchings. (1966). Thioguanine in Deoxyribonucleic Acid from Tumors of 6-Mercaptopurine-Treated Mice. Experimental Biology and Medicine. 122(3). 627–629. 27 indexed citations
18.
SCANNELL, JAMES P. & Frank Worthington Allen. (1960). Synthesis of 3-β-D-Ribofuranosyluracil and 1-Methyl-3-β-D-ribofuranosyluracil1. The Journal of Organic Chemistry. 25(12). 2143–2147. 10 indexed citations
19.
SCANNELL, JAMES P., Arthur M. Crestfield, & Frank Worthington Allen. (1959). Methylation studies on various uracil derivatives and on an isomer of uridine isolated from ribonucleic acids. Biochimica et Biophysica Acta. 32. 406–412. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026